Patent · US Active

Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract

US8623626B2 · kind B2 · utility

0Cited by
1References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 26, 2010
Grant dateJan 7, 2014
Priority date
Expiry dateApr 11, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P21/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

It is intended to provide an extract, kit and a process for synthesizing a protein in a cell-free system. The extract is characterized by being prepared from mutant Escherichia coli cells having a mutation in the ribosomal protein S12 gene. In a preferred embodiment, the mutation is such a mutation as conferring a resistance or dependence to streptomycin on E. coli whereby the reading efficiency of mRNA codon on ribosomes can be improved and thus the protein productivity can be elevated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.